Gin-Gin Gan, Diana-Leh-Ching Ng, Jesinda Pauline Kerishnan, Chong-Guan Ng
{"title":"性功能障碍及其对女性血液病癌症患者生活质量的影响:马来西亚的一项横断面研究","authors":"Gin-Gin Gan, Diana-Leh-Ching Ng, Jesinda Pauline Kerishnan, Chong-Guan Ng","doi":"10.1007/s00520-025-09726-w","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>S exual dysfunction (SD) and quality of life (QoL) are significantly impacted by cancer and its treatments. However, information on sexual function is scarce, particularly among female patients with underlying haematological malignancies in Asia. This study is aimed at determining the prevalence of SD in these patients, identifying associated factors, and examining their effects on QoL.</p><p><strong>Methods: </strong>This cross-sectional study, conducted in Malaysia from 2014 to 2016, involved female patients with haematological malignancies who were on active treatment or had completed active treatment. Sociodemographic and clinical data were obtained through patient interviews and medical records. Sexual functions were assessed using the Female Sexual Function Index, psychological aspects with the Hospital Anxiety and Depression Scale (HADS), and health-related QoL using the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30 version 3.0 questionnaire. Data were analysed using SPSS software.</p><p><strong>Results: </strong>Of the 89 patients recruited, 82% reported SD. Significant associations were found between SD and menopause (OR, 5.7; 95% CI, 1.60-20.34; p = 0.007) and higher HADS-depression score (OR, 1.6; 95% CI, 1.14-2.21; p = 0.006). Patients with SD exhibited lower median scores in Global Health Status/QoL (QL2) (66.7 [IQR 33.3] vs. 91.7 [IQR 33.3], p = 0.009), role function (83.3 [IQR 33.3] vs. 100 [IQR 16.7], p = 0.033), cognitive function (83.3 [IQR 25.0] vs. 100 [IQR 16.7]), and pain (33.3 [IQR 33.3] vs. 0 [IQR 16.7]). Weak positive correlations were observed between FSFI score and QL2 (Rs = 0.252, p = 0.018) and cognitive function (Rs = 0.237, p = 0.026), while a moderate positive correlation was found with role function (Rs = 0.315, p = 0.003).</p><p><strong>Conclusions: </strong>SD is highly prevalent in female patients with haematological cancers, significantly impacting QoL, and this needs to be addressed accordingly.</p>","PeriodicalId":22046,"journal":{"name":"Supportive Care in Cancer","volume":"33 8","pages":"693"},"PeriodicalIF":2.8000,"publicationDate":"2025-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12263468/pdf/","citationCount":"0","resultStr":"{\"title\":\"Sexual dysfunction and its impact on quality of life among female haematological cancer patients: a cross-sectional study in Malaysia.\",\"authors\":\"Gin-Gin Gan, Diana-Leh-Ching Ng, Jesinda Pauline Kerishnan, Chong-Guan Ng\",\"doi\":\"10.1007/s00520-025-09726-w\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>S exual dysfunction (SD) and quality of life (QoL) are significantly impacted by cancer and its treatments. However, information on sexual function is scarce, particularly among female patients with underlying haematological malignancies in Asia. This study is aimed at determining the prevalence of SD in these patients, identifying associated factors, and examining their effects on QoL.</p><p><strong>Methods: </strong>This cross-sectional study, conducted in Malaysia from 2014 to 2016, involved female patients with haematological malignancies who were on active treatment or had completed active treatment. Sociodemographic and clinical data were obtained through patient interviews and medical records. Sexual functions were assessed using the Female Sexual Function Index, psychological aspects with the Hospital Anxiety and Depression Scale (HADS), and health-related QoL using the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30 version 3.0 questionnaire. Data were analysed using SPSS software.</p><p><strong>Results: </strong>Of the 89 patients recruited, 82% reported SD. Significant associations were found between SD and menopause (OR, 5.7; 95% CI, 1.60-20.34; p = 0.007) and higher HADS-depression score (OR, 1.6; 95% CI, 1.14-2.21; p = 0.006). Patients with SD exhibited lower median scores in Global Health Status/QoL (QL2) (66.7 [IQR 33.3] vs. 91.7 [IQR 33.3], p = 0.009), role function (83.3 [IQR 33.3] vs. 100 [IQR 16.7], p = 0.033), cognitive function (83.3 [IQR 25.0] vs. 100 [IQR 16.7]), and pain (33.3 [IQR 33.3] vs. 0 [IQR 16.7]). Weak positive correlations were observed between FSFI score and QL2 (Rs = 0.252, p = 0.018) and cognitive function (Rs = 0.237, p = 0.026), while a moderate positive correlation was found with role function (Rs = 0.315, p = 0.003).</p><p><strong>Conclusions: </strong>SD is highly prevalent in female patients with haematological cancers, significantly impacting QoL, and this needs to be addressed accordingly.</p>\",\"PeriodicalId\":22046,\"journal\":{\"name\":\"Supportive Care in Cancer\",\"volume\":\"33 8\",\"pages\":\"693\"},\"PeriodicalIF\":2.8000,\"publicationDate\":\"2025-07-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12263468/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Supportive Care in Cancer\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s00520-025-09726-w\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"HEALTH CARE SCIENCES & SERVICES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Supportive Care in Cancer","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00520-025-09726-w","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
Sexual dysfunction and its impact on quality of life among female haematological cancer patients: a cross-sectional study in Malaysia.
Background: S exual dysfunction (SD) and quality of life (QoL) are significantly impacted by cancer and its treatments. However, information on sexual function is scarce, particularly among female patients with underlying haematological malignancies in Asia. This study is aimed at determining the prevalence of SD in these patients, identifying associated factors, and examining their effects on QoL.
Methods: This cross-sectional study, conducted in Malaysia from 2014 to 2016, involved female patients with haematological malignancies who were on active treatment or had completed active treatment. Sociodemographic and clinical data were obtained through patient interviews and medical records. Sexual functions were assessed using the Female Sexual Function Index, psychological aspects with the Hospital Anxiety and Depression Scale (HADS), and health-related QoL using the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30 version 3.0 questionnaire. Data were analysed using SPSS software.
Results: Of the 89 patients recruited, 82% reported SD. Significant associations were found between SD and menopause (OR, 5.7; 95% CI, 1.60-20.34; p = 0.007) and higher HADS-depression score (OR, 1.6; 95% CI, 1.14-2.21; p = 0.006). Patients with SD exhibited lower median scores in Global Health Status/QoL (QL2) (66.7 [IQR 33.3] vs. 91.7 [IQR 33.3], p = 0.009), role function (83.3 [IQR 33.3] vs. 100 [IQR 16.7], p = 0.033), cognitive function (83.3 [IQR 25.0] vs. 100 [IQR 16.7]), and pain (33.3 [IQR 33.3] vs. 0 [IQR 16.7]). Weak positive correlations were observed between FSFI score and QL2 (Rs = 0.252, p = 0.018) and cognitive function (Rs = 0.237, p = 0.026), while a moderate positive correlation was found with role function (Rs = 0.315, p = 0.003).
Conclusions: SD is highly prevalent in female patients with haematological cancers, significantly impacting QoL, and this needs to be addressed accordingly.
期刊介绍:
Supportive Care in Cancer provides members of the Multinational Association of Supportive Care in Cancer (MASCC) and all other interested individuals, groups and institutions with the most recent scientific and social information on all aspects of supportive care in cancer patients. It covers primarily medical, technical and surgical topics concerning supportive therapy and care which may supplement or substitute basic cancer treatment at all stages of the disease.
Nursing, rehabilitative, psychosocial and spiritual issues of support are also included.